SCHEMBL2872115

SCHEMBL2872115

CCSc1ccc(Cc2ccc(C(=O)Cl)s2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
POLB P06746 2/20 0.39
RECQL P46063 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
BLM P54132 1/20 0.39
SLC6A4 P31645 9/20 0.38
SLC5A2 P31639 1/20 0.38
MAOA P21397 1/20 0.36
KMT2A Q03164 3/20 0.36
APEX1 P27695 1/20 0.36
EPHX2 P34913 1/20 0.36
MEN1 O00255 2/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 1/20 0.35
RAB9A P51151 3/20 0.33
NPC1 O15118 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HTT P42858 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2863268 0.85 TBXA2R (0.38) MAPTPOLBRECQLTDP1L3MBTL1
SCHEMBL2871214 0.82 MAPT (0.37) MAPTPOLBRECQLTDP1L3MBTL1
SCHEMBL2869145 0.79 MAPT (0.46) MAPTPOLBL3MBTL1KMT2AMEN1
SCHEMBL2864616 0.77 POLB (0.46) MAPTPOLBTDP1L3MBTL1HPGD
SCHEMBL29130679 0.77 ALOX5 (0.44) MAPTPOLBRECQLTDP1L3MBTL1
SCHEMBL2868204 0.75 LOX (0.39) EPHX2
SCHEMBL2864886 0.75 KDM4E (0.49) LMNAALDH1A1
SCHEMBL2872180 0.73 POLB (0.48) MAPTPOLBL3MBTL1SLC5A2KMT2A
SCHEMBL1879193 0.72 ALDH1A1 (0.54) MAPTPOLBRECQLTDP1KMT2A
SCHEMBL2863556 0.72 TP53 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691898-B2 Phosphonic acid derivatives and the treating agents of diseases related hyperphosphatemia KOTOBUKI PHARMACEUTICAL CO., LTD. (JP) 2010-04-06 US disclosed
US-20080119441-A1 Phosphonic Acid Derivatives and the Treating Agents of Diseases Related Hyperphosphatemia KOTOBUKI PHARMACEUTICAL CO., LTD. (JP) 2008-05-22 US disclosed
EP-1813620-A1 PHOSPHONIC ACID DERIVATIVE AND THERAPEUTIC AGENT FOR DISEASE IN WHICH HIGH PHOSPHATE LEVEL IN BLOOD PARTICIPATES Kotobuki Pharmaceutical Co., Ltd. (JP) 2007-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119441-A1 Phosphonic Acid Derivatives and the Treating Agents of Diseases Related Hyperphosphatemia NR0B1, NR0B2, PTH1R MAPT 4759/4885POLB 2456/4885RECQL 1897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.